'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge

Medicines that enable dramatic weight loss are likely to experience a new boom in uptake, experts have said, as the first generic versions hit the market this week at a lower cost than the original drugs. The injections, dubbed "skinny jabs" by the media, can help people lose more than 10% of their body weight and have become hugely popular in recent years, with celebrities lauding their effects. They include Wegovy and Saxenda, which are licensed for weight loss, and Ozempic and Victoza which are licensed for type 2 diabetes but are often prescribed "off-label" as a weight-loss aid. All…